Skip to main content
. Author manuscript; available in PMC: 2014 Sep 1.
Published in final edited form as: Pediatr Blood Cancer. 2013 Mar 28;60(9):1452–1457. doi: 10.1002/pbc.24541

Table II.

DLTs Summary

Dose Level No. of Patients Entered No. of Patients Evaluable No. of Patients with DLT DLT Detail (n)
230 mg/m2 Vorinostat and 150 mg/m2 Temozolomide 6 6 0
300 mg/m2 Vorinostat and 150 mg/m2 Temozolomide 7 6 0
300 mg/m2 Vorinostat and 200 mg/m2 Temozolomide 6 6 4 Neutropenia (3)
Thrombocytopenia (4)
Leucopenia (1)

DLT – Dose limiting toxicity